TCL Archive Celebrex Studied As Potential Prevention Of Lung Cancer In High-Risk Populations August 31, 2001
TCL Archive Lilly drug Alimta misses the target, but wins ODAC endorsement for lung cancer. FDA’s Pazdur tells ODAC that decision on Alimta requires clinical judgment. July 30, 2004